Canada markets open in 1 hour 20 minutes

Valeo Pharma Inc. (VPHIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0800-0.0250 (-23.81%)
At close: 09:53AM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-10-31
2022-10-31
2021-10-31
2020-10-31
Total Revenue
27,745
53,910
27,745
13,557
7,470
Cost of Revenue
21,464
40,833
21,464
9,602
6,089
Gross Profit
6,281
13,077
6,281
3,955
1,381
Operating Expenses
Research Development
-
-
-
-
0
Selling General and Administrative
24,901
29,152
24,478
15,720
5,094
Total Operating Expenses
25,391
30,305
25,391
16,525
5,681
Operating Income or Loss
-19,110
-17,228
-19,110
-12,570
-4,300
Interest Expense
6,461
13,790
6,461
1,356
598
Total Other Income/Expenses Net
-1,483
-512
-1,483
-276
152
Income Before Tax
-26,920
-27,808
-26,920
-14,233
-4,761
Income Tax Expense
0
0
-1,174
0
-
Income from Continuing Operations
-25,746
-27,808
-25,746
-14,233
-4,761
Net Income
-25,746
-27,808
-25,746
-14,233
-4,761
Net Income available to common shareholders
-25,746
-27,808
-25,746
-14,233
-4,761
Basic EPS
-0.20
-0.32
-0.32
-0.20
-0.08
Diluted EPS
-0.20
-0.32
-0.32
-0.20
-0.08
Basic Average Shares
69,930
86,117
80,859
69,930
57,909
Diluted Average Shares
69,930
86,117
80,859
69,930
57,909